Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

375 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus.
Ebert MP, Fischbach W, Hollerbach S, Höppner J, Lorenz D, Stahl M, Stuschke M, Pech O, Vanhoefer U, Porschen R; Weitere Mitglieder der Leitlinienkommission. Ebert MP, et al. Among authors: stuschke m. Z Gastroenterol. 2024 Apr;62(4):535-642. doi: 10.1055/a-2239-9802. Epub 2024 Apr 10. Z Gastroenterol. 2024. PMID: 38599580 Free article. German. No abstract available.
S3-Leitlinie – Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus.
Porschen R, Fischbach W, Gockel I, Hollerbach S, Hölscher A, Jansen PL, Miehlke S, Pech O, Stahl M, Thuss-Patience P, Vanhoefer U; und die Mitarbeiter der Leitlinienkommission; Collaborators:. Porschen R, et al. Z Gastroenterol. 2019 Mar;57(3):336-418. doi: 10.1055/a-0833-5712. Epub 2019 Mar 12. Z Gastroenterol. 2019. PMID: 30861559 Free article. German. No abstract available.
S3-Leitlinie – Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus.
Porschen R, Fischbach W, Gockel I, Hollerbach S, Hölscher A, Jansen PL, Miehlke S, Pech O, Stahl M, Thuss-Patience P, Vanhoefer U; und die Mitarbeiter der Leitlinienkommission; Collaborators:. Porschen R, et al. Z Gastroenterol. 2019 Mar;57(3):e120. doi: 10.1055/a-0884-5474. Epub 2019 Apr 5. Z Gastroenterol. 2019. PMID: 30952167 German. No abstract available.
Head-to-head comparison of 68 Ga-FAPI-46 PET/CT, 18F-FDG PET/CT, and contrast-enhanced CT for the detection of various tumors.
Watanabe M, Fendler WP, Grafe H, Hirmas N, Hamacher R, Lanzafame H, Pabst KM, Hautzel H, Aigner C, Kasper S, von Tresckow B, Stuschke M, Kümmel S, Lugnier C, Hadaschik B, Grünwald V, Zarrad F, Kersting D, Siveke JT, Herrmann K, Weber M. Watanabe M, et al. Among authors: stuschke m. Ann Nucl Med. 2024 Oct 23. doi: 10.1007/s12149-024-01993-7. Online ahead of print. Ann Nucl Med. 2024. PMID: 39443386
Impact of 18F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center Trial.
Jannusch K, Umutlu L, Kirchner J, Bruckmann NM, Morawitz J, Herrmann K, Fendler WP, Bittner AK, Hoffmann O, Mohrmann S, Ruckhäberle E, Stuschke M, Schmid W, Giesel F, Häberle L, Esposito I, Budach W, Grueneisen J, Matuschek C, Kowall B, Stang A, Antoch G, Buchbender C. Jannusch K, et al. Among authors: stuschke m. J Nucl Med. 2024 Oct 10:jnumed.124.268065. doi: 10.2967/jnumed.124.268065. Online ahead of print. J Nucl Med. 2024. PMID: 39389629
Oligometastatic non-small cell lung cancer: Impact of local and contemporary systemic treatment approaches on clinical outcome.
Wiesweg M, Küter C, Schnorbach J, Keyl J, Metzenmacher M, Cvetkovic J, Saalfeld FC, Glanemann F, Eberhardt W, Oezkan F, Theegarten D, Stenzinger A, Darwiche K, Koschel D, Herth F, Bölükbas S, Winter H, Weykamp F, Wermke M, Stuschke M, Plönes T, Thomas M, Schuler M, Christopoulos P. Wiesweg M, et al. Among authors: stuschke m. Int J Cancer. 2024 Sep 25. doi: 10.1002/ijc.35199. Online ahead of print. Int J Cancer. 2024. PMID: 39319506
Theranostics with somatostatin receptor antagonists in SCLC: Correlation of 68Ga-SSO120 PET with immunohistochemistry and survival.
Mavroeidi IA, Romanowicz A, Haake T, Wienker J, Metzenmacher M, Darwiche K, Oezkan F, Bölükbas S, Stuschke M, Umutlu L, Opitz M, Nader M, Hamacher R, Siveke J, Winantea J, Fendler WP, Wiesweg M, Eberhardt WEE, Herrmann K, Theegarten D, Schuler M, Hautzel H, Kersting D. Mavroeidi IA, et al. Among authors: stuschke m. Theranostics. 2024 Aug 26;14(14):5400-5412. doi: 10.7150/thno.98819. eCollection 2024. Theranostics. 2024. PMID: 39310095 Free PMC article.
Survivorship program including long-term toxicities and quality-of-life development over 10 years in a randomized trial in operable stage III non-small-cell lung cancer (ESPATUE).
Schulte C, Gauler T, Pöttgen C, Friedel G, Kopp HG, Fischer B, Schmidberger H, Kimmich M, Budach W, Cordes S, Wienker J, Metzenmacher M, de Los Rios RH, Spengler W, De Ruysscher D, Belka C, Welter S, Luetke-Brintrup D, Guberina M, Oezkan F, Darwiche K, Schuler M, Jöckel KH, Aigner C, Stamatis G, Stuschke M, Eberhardt WEE. Schulte C, et al. Among authors: stuschke m. Int J Cancer. 2024 Aug 28. doi: 10.1002/ijc.35131. Online ahead of print. Int J Cancer. 2024. PMID: 39198970
375 results